Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about Mounjaro

Recent news which mentions Mounjaro

Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum

April 29, 2025

Weight Loss Drugs Soar While Global Obesity Rates Climb, To Hit 50% Of Adults By 2050 Says New Report

March 06, 2025

Elon Musk Admits To Using Weight Loss Medication Criticized By RFK Jr, Says He Prefers Mounjaro Over Miracle Drug Ozempic

December 28, 2024

Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?

December 26, 2024

Eli Lilly's $15 Billion Buyback Faces Stiff Resistance On The Charts

December 10, 2024

Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs

November 21, 2024

Eli Lilly Stock Eyes Worst Month Since February 2009: Is It Time To Buy The Dip?

November 19, 2024

Zepbound, Mounjaro Maker Eli Lilly Climbs In Wednesday Pre-Market As Impressive 51% YTD Gain Sparks Stock Split Speculation

October 30, 2024

Eli Lilly Q3 Earnings On Deck: Stock Split Rumors Heat Up With Weight Loss Gains

October 29, 2024

Eli Lilly Aims To Expand Weight-Loss Drug Trials To Those At Risk, Not Just Overweight

October 01, 2024

Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments

September 25, 2024

Eli Lilly Pumps $800M Into Irish Operations To Meet Skyrocketing Demand For Mounjaro, Zepbound

September 12, 2024

Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern

September 05, 2024

Eli Lilly's Q2 Sales Surge 36%, Analysts Cautious On Future Supply, Market Dynamics; Optimistic About Next-Gen Oral Weight-Loss Drug

August 09, 2024

Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows

July 09, 2024

Eli Lilly Expands Fight Against Counterfeit Obesity Drug Zepbound With New Legal Actions

June 20, 2024

'Not Just A Weight Loss Story:' Eli Lilly CEO Thinks It's Possible To Meet BofA's $60B Revenue Projection From New Drug Launches

May 28, 2024

South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next

May 23, 2024

EXCLUSIVE: GameStop, AMC Buzz 'May Prove To Be Short-Lived,' CEO Of Company Behind MEME ETF Tells Benzinga

May 17, 2024

Eli Lilly Struggles To Keep Pace With Mounjaro, Zepbound Demand: 'Currently Unavailable' On Amazon Pharmacy

April 03, 2024

Costco Long Known For Rotisserie Chicken And Hot Dogs Counters Junk Food With Weight Loss Plan To Help You Shed Those Extras

April 03, 2024

Is Eli Lilly Winning The War On Weight Loss Drugs? Zepbound Overtakes Wegovy In US Prescriptions

March 20, 2024

Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors

February 26, 2024

Jim Cramer Warns Weight Loss Drugs Ozempic, Wegovy And Others Could Impact Food Stocks: 'That Day Will Come'

February 13, 2024

Is Tesla Still A Magnificent 7 Stock? EV Maker Could Get Bumped By These Companies

February 09, 2024

Eli Lilly Soars On Diabetes And Obesity Drug Boom, Projects 20% Revenue Increase In 2024

February 06, 2024

Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs Won't Floor Novo, Eli Shares

January 31, 2024

Tesla's Market Cap Dips Below Eli Lilly Following Q4 Revenue Miss: Report

January 25, 2024

Inflation-Busting Price Hikes For Ozempic, Mounjaro And Others: Are Drugmakers Profiteering?

January 18, 2024

Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them'

December 08, 2023

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.